Forensic Size of Platform Quality Marker Scope Security Stability Safety -------- ------- ------ ----- -------- --------- ------ SigNature Highest Large and Extremely Cannot be Stable Safe, DNA complex flexible copied against "Green" physical Botanical and chemical extremes Non DNA Low to Varies Limited Most are Can be Varies Taggants None copied by unstable counterfeitersThe forensic utility of DNA has survived scrutiny unparalleled for crime evidence. Its informational content is massive and it is one of the most sensitively detected molecules known to man. Applied DNA's products may be deployed in extruded plastics, inks and metal surfaces, making this security applicable to microchips and printed circuits. The company has successfully incorporated DNA in a wide menu of commercial inks, adhesives, label and packaging materials and directly onto a variety of products such as fabrics, cosmetic products and drug prototypes. Dr. Hayward continued: "Once a counterfeit product enters a supply chain, it becomes exceedingly difficult to differentiate a real product from the fake. We regard DNA as the "security of both first and last resort." APDN has been selected to present at the DMSMS and Standardization Conference in Orlando, FL on September 23rd. This will be APDN's second governmental conference demonstrating the power of DNA to successfully address the challenges of counterfeiting and diversion. About APDN APDN sells patented DNA security solutions to protect products, brands and intellectual property from counterfeiting and diversion. SigNature DNA is a botanical mark used to authenticate products in a unique manner that essentially cannot be copied. APDN also provides BioMaterial GenoTyping™ by detecting genomic DNA in natural materials to authenticate finished products. Both technologies protect brands and products in a wide range of industries and provide a forensic chain of evidence that can be used to prosecute perpetrators. To learn more, go to www.adnas.com where APDN routinely posts all press releases. The statements made by APDN may be forward-looking in nature and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K, filed on December 16, 2008 and our subsequent quarterly reports on Form 10-Q. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.
Contact Information: INVESTOR CONTACT: Debbie Bailey 631-444-8090 fax: 631-444-8848 MEDIA CONTACT: Janice Meraglia 631-444-6293 fax: 631-444-8848 FCMN Contact: Web site: http://www.adnas.com